Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NMDA Receptor Antagonist Treatment of Neurodegenerative Disease

NCT00001365 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.

NCT NCT00001365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NMDA Receptor Antagonist Treatment of Neurodegenerative Disease
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Phase
Phase 2
Overall status
Completed
Start date
July 31, 1993
Completion date
June 30, 2001
Enrollment
42
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurodegenerative disease, parkinson's disease